GENTEX CORP (GNTX) › Cash & EquivalentsGENTEX CORP (GNTX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2007: $317.72M2008: $294.31M2009: $336.11M2010: $348.35M2011: $357.99M2012: $389.68M2013: $309.59M2014: $497.43M2015: $551.56M2016: $546.48M2017: $569.73M2018: $217.03M2019: $296.32M2020: $423.37M2021: $262.31M2022: $214.75M2023: $226.44M2024: $233.32M2025: $145.65M$145.65M2007Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$145.65M-37.6%2024$233.32M+3.0%2023$226.44M+5.4%2022$214.75M-18.1%2021$262.31M-38.0%2020$423.37M+42.9%2019$296.32M+36.5%2018$217.03M-61.9%2017$569.73M+4.3%2016$546.48M-0.9%2015$551.56M+10.9%2014$497.43M+60.7%2013$309.59M-20.6%2012$389.68M+8.9%2011$357.99M+2.8%2010$348.35M+3.6%2009$336.11M+14.2%2008$294.31M-7.4%2007$317.72M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share